Inhibition of ameloblastoma invasion in vitro and in vivo by inhibitor of metalloproteinase-2 activity
- PMID: 19473446
- DOI: 10.1111/j.1600-0714.2009.00771.x
Inhibition of ameloblastoma invasion in vitro and in vivo by inhibitor of metalloproteinase-2 activity
Abstract
Background: Ameloblastoma is an odontogenic benign tumor characterized by local invasiveness and most of its local recurrences clinically result from local invasion. This study used matrix metalloproteinase-2 (MMP-2) inhibitor I (MMP-2I) to investigate the role played by MMP-2 activity in the local invasiveness of ameloblastoma.
Methods: The cells and xenografts of ameloblastoma were treated with MMP-2I and treatment group were compared with the control group. In vitro, the invasive activity of tumor cells was assayed in transwell cell culture chamber. Gelatinolytic activity of gelatinases and MMP-2/tissue inhibitor of matrix metalloproteinase (TIMP-2) protein expression was detected using gelatin zymography and flow cytometry. The cell viability and adhesion were evaluated using methyl thiazol tetrazolium. In vivo, bilateral subrenal capsule xenograft transplantation of ameloblastoma was performed in 10 nude mice and the invasion of ameloblastoma into the renal parenchyma was observed.
Results: Active-MMP-2 of conditioned media was significantly lower in treatment group than in the control group. Accordingly, potential of in vitro cell invasion, adhesion and in vivo tumor invasion were also significantly lower in the treatment group than in the control group.
Conclusions: Inhibitor of MMP-2 activity suppressed the local invasive capability of ameloblastoma by decreasing MMP-2 activity. MMP-2 activity is in relation with invasive capacity of ameloblastoma.
Similar articles
-
Tissue inhibitor of metalloproteinase-2 inhibits ameloblastoma growth in a new mouse xenograft disease model.J Oral Pathol Med. 2010 Jan;39(1):94-102. doi: 10.1111/j.1600-0714.2009.00812.x. Epub 2009 Nov 6. J Oral Pathol Med. 2010. PMID: 19895658
-
Inhibition of gelatinolytic activity in tumor tissues by synthetic matrix metalloproteinase inhibitor: application of film in situ zymography.Clin Cancer Res. 2000 Aug;6(8):3290-6. Clin Cancer Res. 2000. PMID: 10955815
-
Expression and role of metalloproteinase-2 and endogenous tissue regulator in ameloblastoma.J Oral Pathol Med. 2010 Mar;39(3):219-22. doi: 10.1111/j.1600-0714.2009.00827.x. Epub 2009 Aug 26. J Oral Pathol Med. 2010. PMID: 19709349
-
Matrix invasion by tumour cells: a focus on MT1-MMP trafficking to invadopodia.J Cell Sci. 2009 Sep 1;122(Pt 17):3015-24. doi: 10.1242/jcs.034561. J Cell Sci. 2009. PMID: 19692588 Review.
-
Ameloblastoma.Am J Clin Oncol. 2007 Dec;30(6):645-8. doi: 10.1097/COC.0b013e3181573e59. Am J Clin Oncol. 2007. PMID: 18091060 Review.
Cited by
-
Comparison of osteoclastogenesis and local invasiveness of ameloblastoma and keratocystic odontogenic tumor.Eur J Dent. 2018 Jan-Mar;12(1):36-42. doi: 10.4103/ejd.ejd_54_17. Eur J Dent. 2018. PMID: 29657523 Free PMC article.
-
Ameloblastoma cell lines derived from different subtypes demonstrate distinct developmental patterns in a novel animal experimental model.J Appl Oral Sci. 2020;28:e20190558. doi: 10.1590/1678-7757-2019-0558. Epub 2020 Apr 27. J Appl Oral Sci. 2020. PMID: 32348439 Free PMC article.
-
Expression of RECK and matrix metalloproteinase-2 in ameloblastoma.BMC Cancer. 2009 Dec 8;9:427. doi: 10.1186/1471-2407-9-427. BMC Cancer. 2009. PMID: 19995435 Free PMC article.
-
Molecular biological findings of ameloblastoma.Jpn Dent Sci Rev. 2021 Nov;57:27-32. doi: 10.1016/j.jdsr.2020.12.003. Epub 2021 Feb 24. Jpn Dent Sci Rev. 2021. PMID: 33737992 Free PMC article. Review.
-
Epigenetic regulation of matrix metalloproteinase expression in ameloblastoma.BMC Clin Pathol. 2012 Aug 6;12:11. doi: 10.1186/1472-6890-12-11. BMC Clin Pathol. 2012. PMID: 22866959 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous